(Q39468688)

English

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study

scientific article published on 23 December 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

0 references

Lynette Pei-Chi Shek

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Chukiat Sirivichayakul

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Elizabeth A Barranco-Santana

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Inés Esquilin-Rivera

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Helen M L Oh

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Marsha Raanan

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Carlos A Sariol

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sriluck Simasathien

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mary Kathryn Smith

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ivan Dario Velez

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Derek Wallace

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gilad S Gordon

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Dan T Stinchcomb

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

23 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

213

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1562-1572

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Dengue: a continuing global threat

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

The global distribution and burden of dengue

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Dengue: an update

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

The future of dengue vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994-2010.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Vaccine-mediated immunity against dengue and the potential for long-term protection against disease

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Critical issues in dengue vaccine development

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Identifying protective dengue vaccines: guide to mastering an empirical process

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Efficacy of a tetravalent dengue vaccine in children in Latin America.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV762

21 January 2018

Research on dengue during World War II

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4269/AJTMH.1952.1.30

Identifiers

10.1093/INFDIS/JIV762

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39468688&oldid=1829696923"